Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob M Rowe

Showing results (1-10 of 275) with videos related to

Pageof 28
Sort By:
Best Practice & Research. Clinical Haematology|October 21, 2004
State of the science for myelodysplastic syndrome: prognosis and promise of new therapiesJacob M Rowe
Best Practice & Research. Clinical Haematology|November 23, 2015
Reasons for optimism in the therapy of acute leukemiaJacob M Rowe
Blood|May 2, 2009
Closer to the truth in AMLJacob M Rowe
Best Practice & Research. Clinical Haematology|December 7, 2013
Important milestones in acute leukemia in 2013Jacob M Rowe
Best Practice & Research. Clinical Haematology|December 3, 2014
The increasing genomic complexity of acute myeloid leukemiaJacob M Rowe
Best Practice & Research. Clinical Haematology|March 25, 2021
Perspectives on current survival and new developments in AMLJacob M Rowe
Best Practice & Research. Clinical Haematology|November 24, 2018
Progress and predictions: AML in 2018Jacob M Rowe
Haematologica|January 5, 2022
The "7+3" regimen in acute myeloid leukemiaJacob M Rowe
Best Practice & Research. Clinical Haematology|March 18, 2008
Consolidation therapy: what should be the standard of care?Jacob M Rowe
Best Practice & Research. Clinical Haematology|September 16, 2008
Graft-versus-disease effect following allogeneic transplantation for acute leukaemiaJacob M Rowe
Pageof 28

Showing results (1-10 of 275) with videos related to

Sort By:
Pageof 28
Best Practice & Research. Clinical Haematology|October 21, 2004
State of the science for myelodysplastic syndrome: prognosis and promise of new therapiesJacob M Rowe
Best Practice & Research. Clinical Haematology|November 23, 2015
Reasons for optimism in the therapy of acute leukemiaJacob M Rowe
Blood|May 2, 2009
Closer to the truth in AMLJacob M Rowe
Best Practice & Research. Clinical Haematology|December 7, 2013
Important milestones in acute leukemia in 2013Jacob M Rowe
Best Practice & Research. Clinical Haematology|December 3, 2014
The increasing genomic complexity of acute myeloid leukemiaJacob M Rowe
Best Practice & Research. Clinical Haematology|March 25, 2021
Perspectives on current survival and new developments in AMLJacob M Rowe
Best Practice & Research. Clinical Haematology|November 24, 2018
Progress and predictions: AML in 2018Jacob M Rowe
Haematologica|January 5, 2022
The "7+3" regimen in acute myeloid leukemiaJacob M Rowe
Best Practice & Research. Clinical Haematology|March 18, 2008
Consolidation therapy: what should be the standard of care?Jacob M Rowe
Best Practice & Research. Clinical Haematology|September 16, 2008
Graft-versus-disease effect following allogeneic transplantation for acute leukaemiaJacob M Rowe
Pageof 28